Revvity, Inc.
NYSE:RVTYMedical - Diagnostics & Research
Healthcare
$152.43 -3.36%
-$3.40 today
- Market cap
- $17.02B
- Beta
- 1.11
- P/E (TTM)
- 45.4
- EPS (TTM)
- $2.15
- Dividend yield
- 0.29%
52W Low $81.22High $118.30
Volume 1.09M
Average 1.27M
Income Statement
Follow revenue through to earnings.
Revenue
$2.86B
FY 2025 · Annual
+3.7% YoYOperating Income
$356.63M
FY 2025 · Annual
-13.1% YoYNet Income
$241.68M
FY 2025 · Annual
-18.3% YoYIncome Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.83B | 3.31B | 2.75B | 2.76B | 2.86B |
| Cost of Revenue | 1.55B | 1.55B | 1.43B | 1.43B | 1.34B |
| Gross Profit | 2.28B | 1.76B | 1.32B | 1.32B | 1.52B |
| Gross Margin | 59.6% | 53.2% | 48.1% | 48.0% | 53.1% |
| Research & Development | 200.34M | 221.62M | 216.58M | 196.84M | 215.84M |
| Selling, General & Admin | 741.61M | 757.99M | 706.12M | 715.3M | 945.29M |
| Operating Expenses | 941.95M | 979.61M | 922.7M | 912.14M | 1.16B |
| Depreciation & Amortization | 311.44M | 427M | 431.77M | 427.85M | 405.34M |
| EBITDA | 1.62B | 1.18B | 713.56M | 840.25M | 765.8M |
| EBITDA Margin | 42.2% | 35.7% | 25.9% | 30.5% | 26.8% |
| Operating Income | 1.34B | 781.12M | 399.49M | 410.52M | 356.64M |
| Operating Margin | 35.0% | 23.6% | 14.5% | 14.9% | 12.5% |
| Interest Income | 2.24M | 3.59M | 72.13M | 73.19M | 31.1M |
| Interest Expense | 102.13M | 103.96M | 98.81M | 96.28M | 92.19M |
| Other Income / Expenses | (136.42M) | (129.29M) | (216.52M) | (94.39M) | (88.36M) |
| Income Before Tax | 1.2B | 651.84M | 182.98M | 316.13M | 268.28M |
| Pre-Tax Margin | 31.4% | 19.7% | 6.7% | 11.5% | 9.4% |
| Income Tax Expense | 314.15M | 139.16M | 3.47M | 33.06M | 25.8M |
| Net Income | 943.16M | 569.18M | (118.38M) | 295.83M | 241.68M |
| Net Margin | 24.6% | 17.2% | -4.3% | 10.7% | 8.5% |
| EPS (Basic) | 8.12 | 4.51 | (0.95) | 2.41 | 2.08 |
| EPS (Diluted) | 8.08 | 4.50 | (0.95) | 2.41 | 2.08 |
| 116.17M | 126.16M | 124.7M | 122.76M | 113.21M | |
| 116.67M | 126.43M | 124.81M | 122.82M | 113.21M |
RVTY Earnings Waterfall · TTM
NYSE:RVTY · Revenue to Net Income
Key Ratios
EPS$2.10
Gross Margin52.3%
Net Margin8.1%
P/E Ratio50.5
P/S Ratio14.9
Analysis
$2.9B of revenue converted into $237.6M of net income for the selected period. Gross margin is 52.3% and net margin is 8.1%, showing how much revenue survives after costs and taxes. EPS is $2.10, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 8-K | Current report | Nov 3, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 7, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 2, 2026 |
How much revenue does RVTY generate?
Revvity, Inc. (RVTY) reported $2.86B of revenue in fiscal 2025.
Is RVTY profitable?
Revvity, Inc. (RVTY) reported $241.68M of net income, with a net margin of 8.5%.
Continue the stock analysis
Jump to another research area for this company.